yesβ¦
07.02.2026 18:47 β π 0 π 0 π¬ 0 π 0@bendinglab.bsky.social
T cell immunology group. Interested in T cell regulation and checkpoint receptor control of adaptive immunity. #CD4Tcells #TCRsignalling #immunotherapy
yesβ¦
07.02.2026 18:47 β π 0 π 0 π¬ 0 π 0How to reconcile the end statement βUKRIβs overall research and innovation budget is risingβ¦β
with earlier
βwe unfortunately expect to make a reduced number of awards to applications currently being assessedβ
This statement if anything makes things worse
www.ukri.org/blog/mrc-fun...
It's today! Our #BSIMidlands25 kicks off with an overview of the history of clinical immunology in the Midlands by Dr Aarnoud Huissoon
20.06.2025 08:52 β π 6 π 3 π¬ 0 π 0We are very proud to introduce our brand new 2025 #ListerFellows! This year there are eight Prize recipients. lister-institute.org.uk/a-warm-welco...
19.06.2025 11:07 β π 22 π 6 π¬ 1 π 8Honoured to receive this prize alongside an inspiring group of scientists. This will support our work to improve mRNA therapies for precision medicine. #mRNA #immunoSky #Science
19.06.2025 11:23 β π 10 π 2 π¬ 2 π 0Lovely work!
15.05.2025 17:49 β π 2 π 0 π¬ 0 π 0PD1 & Lag3 regulate TCR signal duration in tolerant CD4 T cells
β’PD-1 & Lag3 exhibit layered control of CD4 T cell activation
β’Co-blockade enhances NFAT-dependent TCR transcription
β’NFAT inhibition reverses functional effects of anti-PD-1&Lag3
doi.org/10.1093/immadv/ltaf015
@imtadvances.bsky.social
Congrats to the team! Very nice study. I find it especially interesting that blocking NFAT can compensate for the effects of anti-PD1/LAG3.
12.05.2025 13:29 β π 1 π 1 π¬ 1 π 0Thank you! Yes, we have only largely looked at a few markers in the functional assays. I think as our model is very TCR signal driven (tolerogenic) it suggests it may more preferentially signal down that pathway. In terms of under co-stimulation or CD8 biology, we have not yet looked!
12.05.2025 13:35 β π 1 π 0 π¬ 0 π 0#immunosky π§ͺ
12.05.2025 08:08 β π 0 π 0 π¬ 0 π 0We are now seeking to understand relevance of these pathways are relevant in the immune related adverse events (irAEs) space and tumour environment!
12.05.2025 08:03 β π 2 π 0 π¬ 1 π 0PD1 & Lag3 regulate TCR signal duration in tolerant CD4 T cells
β’PD-1 & Lag3 exhibit layered control of CD4 T cell activation
β’Co-blockade enhances NFAT-dependent TCR transcription
β’NFAT inhibition reverses functional effects of anti-PD-1&Lag3
doi.org/10.1093/immadv/ltaf015
@imtadvances.bsky.social
π₯ Open postdoc position in human inflammation-driven control of infection! π₯
Join me at the University of Geneva, Switzerland this summer as Iβm moving my Wellcome-funded research activity to the Department of Microbiology and Molecular Medicine! (1/5)
Please share!
Our new blog post spotlights the Lister Institute's ties with @unibirmingham.bsky.social, home to Lister Fellows past and present @bendinglab.bsky.social @agagambus.bsky.social @sarahdimeloe.bsky.social sky.social @therad-lab.bsky.social @tunglejic.bsky.social lister-institute.org.uk/shining-a-li...
14.04.2025 14:33 β π 3 π 2 π¬ 0 π 0#Immunology out now @science.org
After initial priming in the lymph nodes, mouse CD8 T cells undergo a second phase of stable interactions with dendritic cells that can preferentially stimulate those with a high-affinity for antigen.
buff.ly/49bKcTG
By Jobin, Seetharama, RΓΌttger et al.
Check out latest work from @bendinglab.bsky.social - new insights into IFNg regulation of TCR signalling! π§ͺ #immunosky
11.04.2025 08:54 β π 8 π 3 π¬ 0 π 0#immunosky π§ͺ
11.04.2025 07:23 β π 0 π 0 π¬ 0 π 0Figure 4 from paper shows how anti-IFNg reduces markers of TCR signal strength and attenuates Tr1 cell differentiation in the Tg4 model
Highlights:
- A single high dose of modified self-peptide induces Tr1 cells
-Tr1 cell development is positively regulated by IFNΞ³
- Anti-IFNΞ³ treatment reduces markers of strong TCR signaling and Tr1 cell frequency
- Blocking IL-27 in combination with anti-IFNΞ³ additively reduces Tr1 cell frequency
Now published @cp-iscience.bsky.social
Work lead by David Lecky & Lozan Sheriff in collaboration with @therad-lab.bsky.social and @cameron-wraith.bsky.social showing how IFNg augments T Cell receptor signal strength to enhance type 1 Regulatory T (Tr1) cell development
www.cell.com/iscience/ful...
Noncanonical T cell responses are associated with protection from tuberculosis in mice and humans
@jem.org
rupress.org/jem/article-...
A new paper from #ListerFellow @linterman.bsky.social and colleagues explores the role of tertiary lymphoid structures (TLS) in #bcell immune response. @pnas.org doi.org/10.1073/pnas...
08.04.2025 12:39 β π 11 π 4 π¬ 0 π 1What better way to get into that Friday feeling than reading our new paper? First author @hlpeks.bsky.social and I will be doing a tutorial on @arrdept-ucldom.bsky.social next Tuesday lunchtime for those who are interested in reading the highlights π
28.03.2025 13:19 β π 10 π 4 π¬ 0 π 0Sex hormones and chromosomes work in tandem to impact immune responses, with estrogen influencing class-switched memory B cell frequency exclusively in humans with an XX chromosomal background. From @hlpeks.bsky.social, @bcellsrosser.bsky.social, Coziana Ciurtin et al. rupress.org/jem/article/...
28.03.2025 13:12 β π 23 π 8 π¬ 1 π 3π£ New Review Alert!
Do you think glial cells are simply neuronal support cells in the CNS?
Did you know glial cells are integral to barrier organs?
Check out our latest review exploring the fascinating crosstalk between glia and immune cells in the gut, lung and skin!
#GlialCells #ImmuneSystem
Excited for our lab's FIRST paper #ScienceImmunology! π
Led by @categraca.bsky.social & Amania Sheikh, with amazing collabs from Axel Kallies, Dane Newman, & @rickyjohnstone.bsky.social
Huge thanks to reviewers & @claireolingy.bsky.social π
#Tpex #onthescoreboard
www.science.org/doi/full/10....
The BSI has grants available for our members who want to help get more people excited about #immunology
16.01.2025 16:40 β π 3 π 1 π¬ 0 π 0β° Last few days before the deadline of midday (GMT) Friday 10 January if you are thinking of applying for one of our Medical Research Council fully funded 4 year PhD studentships at our partner institutions @uniofnottingham.bsky.social @unibirmingham.bsky.social or University of Leicester π§΅
07.01.2025 11:49 β π 1 π 1 π¬ 1 π 1